AIM Vaccine Schedules 23 August 2026 Board Meeting to Approve 1H 2026 Interim Results and Potential Dividend
Bulletin Express
Aug 12
AIM Vaccine Co., Ltd. has notified shareholders that its Board of Directors will convene on Sunday, 23 August 2026.
The agenda includes:
1. Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.
2. Considering a recommendation for the payment of an interim dividend, if any.
3. Addressing other routine business matters.
The meeting will be chaired by Chairman and CEO Mr. Yan Zhou. The Board currently comprises six executive directors, one non-executive director and four independent non-executive directors.
The notice was released in Hong Kong on 12 August 2026. Stakeholders can expect publication of the interim results following Board approval.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.